Explore / Clinical trial
Clinical trial

Repeat Dosing of Psilocybin in Migraine Headache

Yale UniversityCompletedPhase 1Started Aug 10, 202118 enrolledUnited StatesNCT04218539

Abstract

In seeking to understand the capacity for psilocybin to reduce migraine headache burden, this study will investigate single and repeated dosing of psilocybin up to two doses. In seeking to identify an underlying mechanism in psilocybin's effects, neuroinflammatory markers for migraine headache will be measured.

Topics & conditions

Detected automatically by Psychedelic Commons from the title and abstract, not labels from the source. They may be incomplete.

PsilocybinPain

Keywords

inflammationcalcitonin gene-related peptide (CGRP)pituitary adenylate cyclase-activating peptide (PACAP)Migraine Headache

Psychedelic Commons aggregates metadata from open sources and links back to the original. Rights remain with the authors and publishers. Something wrong with this record? Report a problem.